Everolimus-figure-1 (Everolimus Fig1)
Everolimus Tablet
Product Images NDC 59651-933
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 59651-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Everolimus-figure-2 (Everolimus Fig2)
This text pertains to a medication called Everolimus Tablets, containing 0.25 mg of Everolimus per tablet. The instructions recommend storing the tablets at a temperature between 20°C to 25°C, protecting them from light and moisture. The pharmacist is instructed to dispense the medication guide provided to each patient separately. Any side effects should be reported to the FDA, and patients are advised to call their doctor for medical advice. The medication is distributed by Aurobindo Pharma USA, Inc. in New Jersey and is manufactured in India. More information can be found in the medication guide available on www.aurobindousa.com/medication-guides.*
Everolimus-fig3 (Everolimus Fig3)
This text provides important information about a medication containing 0.5 mg of Everolimus, specifically a prescription drug in the form of 60 tablets. It mentions possible side effects and advises patients to report them to the FDA. The dosage instructions and storage conditions are also included. The medication is distributed by Aurobindo Pharma USA, Inc., with its address in New Jersey. The text emphasizes the need to keep the drug out of the reach of children and protect it from light and moisture.*
Everolimus-fig4 (Everolimus Fig4)
Each tablet contains 0.75 mg of Everolimus. Follow the dosage instructions provided in the package insert available at www.aurobindousa.com/medication-guides. Store the medication at 20° to 25°C (68° to 77°F) with excursions permitted between 15° and 30°C (59° and 86°F). Protect from light and moisture. Keep out of reach of children. For medical advice, contact your doctor and report any side effects to FDA at 1-800-FDA-1088. This medication is distributed by Aurobindo Pharma USA, Inc.*
Everolimus-fig5 (Everolimus Fig5)
Each tablet contains 1 mg Everolimus. The medication guide can be printed through NDC 59651-934-60. The tablets are to be stored between 59°F and 86°F at Aurobindo Pharma USA, Inc. in East Windsor, NJ. Protect the tablets from light and moisture. The pharmacist should dispense the medication guide separately to each patient. Side effects can be reported to FDA at 1-800-FDA-1088. Keep these tablets out of reach of children.*
Everolimus-structure (Everolimus Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
